LRG GIST Patient Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorThe Life Raft Group
About this trial
The Life Raft Group (LRG) Patient Registry is a structured database that collects comprehensive information about individuals diagnosed with GIST. The purpose of this registry is to facilitate research, improve understanding of the disease, track patient outcomes, and ultimately enhance patient care.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Gastrointestinal Stromal Tumor diagnosis
Provide written and informed consent
Disqualifiers
None
Trial population
Gastrointestinal Stromal Tumor diagnosis
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Overall survival
Time from registry enrollment until death from any cause.
Time frame
From the date of registry enrollment until death from any cause, assessed through follow-up for up to 25 years.2
Progression Free Survival
Time from registry enrollment until documented disease progression or death, whichever occurs first.
Time frame
From the date of registry enrollment until the first documented disease progression or death from any cause, whichever occurs first, assessed through follow-up for up to 25 years.3
Recurrence Free Survival
Time from registry enrollment (or from complete surgical resection, if that is the clinically relevant starting point) until the first documented recurrence of GIST or death from any cause, whichever occurs first.
Time frame
From the date of complete surgical resection until the first documented recurrence of GIST or death from any cause, whichever occurs first, assessed through follow-up for up to 25 years.4
Disease Free Survival
Disease-free survival is defined as the time from complete surgical resection of localized GIST until the first documented recurrence of GIST or death from any cause, whichever occurs first.
Time frame
From the date of complete surgical resection until the first documented recurrence of GIST or death from any cause, whichever occurs first, assessed through follow-up for up to 25 years.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov